FSANZ rejects scientists’ concerns about the safety of GM wheat

Food Standards Australia and New Zealand has responded to criticisms of its regulation of GM foods by Canterbury University’s Professor Jack Heinemann, who accused it of “systemic neglect”.

Heinemann, Dr Judy Carman and the Australian anti-GM activist group Safe Food Foundation two months ago released a paper suggesting GM wheat being developed by Australia’s CSIRO could cause liver damage in humans. In an accompanying media statement, the foundation warned of “devastating consequences causing serious illness or death”.

The paper was criticised by scientists because it had not been through peer review by a major journal.

A post at Sciblogs today recalls the subsequent robust debate on its blog site, including Prof Heinemann contributing a guest post.

The FSANZ has now issued a statement (here) along with its full report on the issue (here).

It says a recent scientific article (Heinemann et al, 2013) claims that small double-stranded RNAs (dsRNAs) generated in GM plants as a result of using gene silencing techniques can create biosafety risks that are not being adequately assessed by regulators such as itself.

The article suggested changes to the safety assessment process to address their concerns.

The FSNZA says it has carefully examined the arguments put forward in the article and has thoroughly researched the scientific literature on gene silencing.

It concludes:

“The weight of scientific evidence published to date does not support the view that small dsRNAs in foods are likely to have adverse consequences for humans.”

The FSNZA says that, in formulating their hypothesis, the authors of the report have not taken into account the fact that small dsRNAs are ubiquitous in the environment and in the diverse range of organisms we consume as food, including plants and animals.

This establishes a long history of safe human consumption which pre-dates the use of such techniques in GM plants.

The authors failed to adequately acknowledge that developing oral therapies based on small dsRNAs targeted against human viruses and other diseases such as cancer has so far been unsuccessful because of the barriers that exist to their uptake, distribution and targeting within the body.

The authors have also underestimated the strengths of the GM food safety assessment to detect possible unintended effects, including those that could arise from the use of gene silencing.
There is no scientific basis for suggesting that small dsRNAs present in some GM foods have different properties or pose a greater risk than those already naturally abundant in conventional foods.

The current case-by-case approach to GM food safety assessment is sufficiently broad and flexible to addresses the safety of GM foods developed using gene silencing techniques. This approach enables additional studies to be requested should that be necessary to further inform the safety assessment of a particular GM food.

The FSANZ says it will continue to monitor the scientific literature for any new developments which may be relevant to GM food safety assessment.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s